Adapalene - Galderma
Alternative Names: CD-271; Differin Gel 0.1%; Differin Gel 0.3%; Differin Lotion 0.1%; Differin XPLatest Information Update: 05 Nov 2023
Price :
$50 *
At a glance
- Originator Galderma
- Class Anti-inflammatories; Antiacnes; Keratolytics; Naphthalenes; Retinoids; Small molecules
- Mechanism of Action Retinoic acid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Acne vulgaris
- Phase III Photodamage
- Discontinued Multiple sclerosis
Most Recent Events
- 13 Apr 2017 Discontinued - Phase-III for Photodamage in USA (Topical)
- 17 Nov 2016 Maruho plans a open label, randomised trial for Acne vulgaris (Combination therapy, In adolescents, In adults) in Japan (UMIN000024874)
- 08 Jul 2016 Adapalene (Topical, gel,0.1%) has been designated as an Over-the-counter (OTC) product in the US